FDA’s Opdivo Lung Cancer Approval

By João L. Carapinha

October 11, 2024

The FDA has approved a new treatment regimen using Opdivo (nivolumab) for resectable non-small cell lung cancer (NSCLC), marking a significant advancemen...
Mental Healthcare for Youth: Addressing Substance Use and Chronic Conditions
Internet Use and Adolescent Mental Health: The Role of Parental Support
Boosting HPV Cervical Cancer Awareness: Key Insights on Public Survey
Strategic Phased Launch of Tirzepatide for Obesity Treatment in England
The Trump Drug Policy Change: A Reverse Course
Created and Validated by FDA: AI Drug Safety Surveillance Tool
Hip Fracture Risk in Elderly Adults: Evaluating Prediction Tools
The Effect of Sedentary Behaviour on Healthy Ageing
The Readiness of Biosimilars in Multiple Sclerosis Treatment
Artificial Intelligence in Elderly Care: Ethical and Responsible Adoption
Healthcare System Responses to Ageing Populations
Elderly Technology Acceptance: Enhancing Health and Independence